Through the activation of thromboxane-A2 receptors (TP), prostacyclin, prostaglandins, isoprostanes, and 20-HETE participate in the endothelial dysfunction associated with cardiovascular risk factors [15]. Here, TBXA2R is linked to endothelial dysfunction.